Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder
Yale University · with National Institute of Mental Health (NIMH) · NCT06834217
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–70 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 180
- US sites recruiting
- 1
- Study start
- September 12, 2025
- Record last updated
- July 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Obsessive-compulsive disorder (OCD) is associated with substantial impairments in quality of life and is among the most disabling psychiatric disorders. Exposure therapy is among the first-line of treatments for obsessive-compulsive disorder (OCD) . Extinction learning is thought to be a core mechanism of therapeutic exposure. Fear and safety signal learning are traditionally associated with activity and connectivity within the canonical corticolimbic "fear circuit", which includes the amygdala, medial prefrontal cortex (mPFC), and hippocampus. Transcranial direct current stimulation (tDCS) is a neuromodulation technology that can augment brain plasticity, learning, and memory. The proposed study will test if obsessive-compulsive disorder (OCD) is associated with inhibitory safety learning deficits and if transcranial direct current stimulation (tDCS) normalizes functional connectivity and safety signal processing to recover extinction deficits in obsessive-compulsive disorder (OCD).
Being studied: Active transcranial direct current stimulation; Sham transcranial direct current stimulation
Conditions: Obsessive Compulsive Disorder (OCD)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- All Participant Inclusion Criteria would include:
- 18 years of age or older
- speak English fluently, and
- able to provide written and verbal informed consent.
- Obsessive-compulsive disorder (OCD) Inclusion Criteria would include:
- meet criteria for OCD as determined by structured clinical interview
- exhibit significant current symptoms of OCD
- report duration of OCD symptoms of at least 1-year
- OCD symptoms are primary or co-primary relative to other psychiatric diagnoses
- stable psychiatric treatment (≥8-weeks) or no active treatment.
- exhibit significant current symptoms of OCD as determined by the Dimensional Obsessive-Compulsive Scale (DOCS) (≥18).
Exclusion Criteria
- All Participant Exclusion Criteria would include:
- active severe substance use disorder(s)
- acute suicidality
- history of bipolar or psychotic disorder(s)
- significant developmental disabilities
- loss of consciousness > 10 minutes
- history of traumatic brain injury
- major neurological disease
- a positive pregnancy test
- other brain stimulation or magnetic resonance imaging contraindications
- new psychological treatment within the past 8 weeks
- daily anxiolytic medication use (e.g., benzodiazepine).
- Non-Clinical Control Exclusion Criteria would include:
- meet current criteria for a psychiatric disorder as determined by structured clinical interview
- active-psychotropic medications.
Recruiting US locations
Temple Medical Center
New Haven, CT 06511
Site contact: Ava Reker, B.A. · 2037854575 · ava.reker@yale.edu
Study contacts (from the official record)
- Thomas Adams, PhD · (203) 974-7523 · thomas.adamsjr@yale.edu
- Ava Reker, B.A. · ava.reker@yale.edu
Similar studies in Connecticut
All mental health studies in Connecticut →- RecruitingHealthy volunteersPhase 1/Phase 2
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
Yale University
- Location
- West Haven, CT
- Eligibility basics
- Ages 21–60
- RecruitingHealthy volunteersPhase 1
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
Deepak C. D'Souza
- Location
- West Haven, CT
- Eligibility basics
- Ages 21–65
- RecruitingHealthy volunteersEarly Phase 1
Cannabidiol Effects on Learning and Anxiety
University of Connecticut
- Location
- Storrs, CT
- Eligibility basics
- Ages 18–50